IN2014DN01468A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN01468A IN2014DN01468A IN1468DEN2014A IN2014DN01468A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A IN 1468DEN2014 A IN1468DEN2014 A IN 1468DEN2014A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A
- Authority
- IN
- India
- Prior art keywords
- oligosaccharide
- composition
- infants
- mixture
- probiotic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000008133 cognitive development Effects 0.000 abstract 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 230000008132 psychomotor development Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Pediatric Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 | ||
| PCT/EP2012/070281 WO2013057049A1 (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01468A true IN2014DN01468A (enExample) | 2015-05-22 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1468DEN2014 IN2014DN01468A (enExample) | 2011-10-18 | 2012-10-12 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (enExample) |
| EP (2) | EP2775852B1 (enExample) |
| CN (1) | CN103889238B (enExample) |
| AU (1) | AU2012325060B2 (enExample) |
| BR (1) | BR112014008944B1 (enExample) |
| CL (1) | CL2014000759A1 (enExample) |
| ES (1) | ES2601891T3 (enExample) |
| IN (1) | IN2014DN01468A (enExample) |
| MX (1) | MX350435B (enExample) |
| MY (1) | MY170185A (enExample) |
| PH (1) | PH12014500443A1 (enExample) |
| PL (1) | PL2775852T3 (enExample) |
| PT (1) | PT2775852T (enExample) |
| RU (1) | RU2607458C2 (enExample) |
| WO (1) | WO2013057049A1 (enExample) |
| ZA (1) | ZA201403591B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011005681A1 (en) | 2009-07-06 | 2011-01-13 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
| DK2708145T3 (en) | 2012-09-14 | 2016-07-18 | Abbott Lab | Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals |
| ES2795665T3 (es) | 2012-09-14 | 2020-11-24 | Abbott Lab | Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa |
| EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
| BR112016012869A2 (pt) * | 2013-12-19 | 2017-08-08 | Nestec Sa | Composição nutricional para reduzir o estresse metabólico em bebês |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| EP3212012A1 (en) | 2014-10-31 | 2017-09-06 | Nestec S.A. | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
| US20170354696A1 (en) * | 2014-11-26 | 2017-12-14 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
| WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
| EP3288389A4 (en) * | 2015-04-28 | 2018-10-10 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| MX379149B (es) * | 2015-08-04 | 2025-03-10 | Soc Des Produits Nestle S A Star | Composiciones nutricionales con 2fl y lnnt para usar en la inducción de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. |
| CN108541221B (zh) * | 2015-12-15 | 2023-02-28 | 格礼卡姆股份公司 | Hmo的混合物 |
| BR112018013534B1 (pt) | 2016-01-26 | 2023-03-07 | Société des Produits Nestlé S.A. | Uso de 2fl e lnnt para controlar a ingestão de alimentos e o crescimento em bebês ou crianças pequenas, e para promoção de um crescimento saudável de um bebê ou criança pequena |
| AU2017213083A1 (en) * | 2016-01-26 | 2018-05-10 | Société des Produits Nestlé S.A. | Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth |
| CN109069555B (zh) * | 2016-04-13 | 2022-07-26 | 株式会社明治 | 面向新生儿的用于改善脑功能的组合物 |
| EP3490567A4 (en) | 2016-07-28 | 2020-03-18 | Fonterra Co-Operative Group Limited | DAIRY PRODUCT AND DAIRY PROCESS |
| CA3051900A1 (en) | 2017-05-04 | 2018-11-08 | The Board Of Trustees Of The Leland Stanford Junior Unversity | Neurodevelopment-promoting food compositions and kits, systems and methods related thereto |
| EP3624786B1 (en) | 2017-05-16 | 2023-07-05 | Ability Pharmaceuticals S.L. | A pharmaceutical combination for the treatment of a cancer |
| US11872238B2 (en) | 2017-05-24 | 2024-01-16 | Societe Des Produits Nestle S.A. | Nutritional composition for use to enhance attention and/or reduce impulsivity |
| US20200305488A1 (en) * | 2017-07-07 | 2020-10-01 | Societe Des Produitis Nestle S.A. | Human milk fortifier |
| CN111093395A (zh) * | 2017-07-07 | 2020-05-01 | 雀巢产品有限公司 | 人乳强化剂 |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| US20230414640A1 (en) | 2020-12-04 | 2023-12-28 | Societe Des Produits Nestle S.A. | Stable aqueous composition for preterm to promote early postnal growth |
| KR102570073B1 (ko) * | 2022-11-17 | 2023-08-24 | (주)에이피테크놀로지 | 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물 |
| CN118285505A (zh) * | 2024-03-29 | 2024-07-05 | 黑龙江飞鹤乳业有限公司 | 促进大脑发育的营养组合物、食品及配方奶粉 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5180674A (en) | 1990-04-16 | 1993-01-19 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| ES2326481T3 (es) * | 2003-06-23 | 2009-10-13 | Nestec S.A. | Formula para recien nacidos o formula de continuacion. |
| CN1863463B (zh) * | 2003-06-23 | 2011-05-04 | 雀巢技术公司 | 用于促进肠道屏障成熟的营养组合物 |
| ES2284028T5 (es) * | 2003-06-30 | 2014-12-04 | Clasado Inc. | Nueva composición de galactooligosacárido y la preparación de la misma |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| CN101400267B (zh) * | 2006-02-10 | 2011-11-23 | 雀巢产品技术援助有限公司 | 寡糖混合物 |
| US9005682B2 (en) | 2006-03-07 | 2015-04-14 | Nestec S.A. | Synbiotic mixture |
| US20080003330A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| US20110195144A1 (en) * | 2007-11-26 | 2011-08-11 | Nestec S.A. | Age-tailored nutrition system for infants |
| US8927698B2 (en) | 2009-04-07 | 2015-01-06 | Glycom A/S | Method for the synthesis of a trisaccharide |
| EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
| EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| AU2010277582A1 (en) * | 2009-07-31 | 2012-02-02 | Nestec S.A. | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| CN105330705A (zh) * | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
| PH12013502290A1 (en) * | 2011-06-08 | 2019-03-22 | Nestec Sa | Nutritional compositions having exogenous milk fat globule membrane components |
-
2012
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 PH PH1/2014/500443A patent/PH12014500443A1/en unknown
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en not_active Ceased
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012325060A1 (en) | 2014-03-13 |
| ES2601891T3 (es) | 2017-02-16 |
| MX350435B (es) | 2017-09-06 |
| CN103889238A (zh) | 2014-06-25 |
| CL2014000759A1 (es) | 2014-08-22 |
| AU2012325060B2 (en) | 2015-11-19 |
| ZA201403591B (en) | 2016-01-27 |
| PL2775852T3 (pl) | 2017-02-28 |
| MX2014004716A (es) | 2015-02-05 |
| WO2013057049A1 (en) | 2013-04-25 |
| EP3095331A1 (en) | 2016-11-23 |
| EP2775852A1 (en) | 2014-09-17 |
| PT2775852T (pt) | 2016-11-08 |
| RU2607458C2 (ru) | 2017-01-10 |
| EP2775852B1 (en) | 2016-08-17 |
| MY170185A (en) | 2019-07-09 |
| BR112014008944B1 (pt) | 2020-09-15 |
| US20140271562A1 (en) | 2014-09-18 |
| RU2014119844A (ru) | 2015-11-27 |
| PH12014500443A1 (en) | 2014-04-14 |
| CN103889238B (zh) | 2017-10-13 |
| BR112014008944A2 (pt) | 2017-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN01468A (enExample) | ||
| PH12012501824A1 (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
| PH12014500509B1 (en) | Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| PH12014500558A1 (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| PH12013501892A1 (en) | Nutritional compositions including branched chain fatty acids for wound healing | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| WO2013049519A3 (en) | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols | |
| BR112012023328A2 (pt) | composições nutricionais | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| BR112013028820A2 (pt) | alimento medicinal para declínio cognitivo | |
| PH12016500690A1 (en) | Probiotic stabilization | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| HK1201067A1 (en) | Sialic acid analogs | |
| WO2011088209A3 (en) | 1-deoxy analogs of vitamin d-related compounds | |
| PH12013502563A1 (en) | Dha and epa in the reduction of oxidative stress | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| NZ709741A (en) | Improvement of cognitive function in preterm infants that are small for gestational age | |
| GB201209344D0 (en) | Omega-6 enriched pufa phospholipids | |
| MX2012012324A (es) | Formulaciones y usos del derivado del acido 2 - hidroxi -5 - fenilazobenzoico para el tratamiento de varones. | |
| MX2015013179A (es) | Formula infantil con bajo contenido calorico que contiene acido beta-hidroxi-beta-metilbutirico. | |
| PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych | |
| TH146972A (th) | องค์ประกอบเพื่อใช้ในการพัฒนาการเติบโตของสมอง และ/หรือ การพัฒนาด้านสติปัญญา และ/หรือ การพัฒนาทางร่างกาย |